The MiRP2-Kv3.4 potassium channel: Muscling in on Alzheimer's disease

Molecular Pharmacology

Volumn 72, Issue 3, 2007, Pages 499-501

  Choi, Eun ^a   Abbott, Geoffrey W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POTASSIUM CHANNEL KV1.3; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL ALPHA SUBUNIT KV 3.4;

ALZHEIMER DISEASE; CELL DEATH; FOLLOW UP; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEA ANEMONE; SHORT SURVEY; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; CELL DEATH; CNIDARIAN VENOMS; HUMANS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; NF-KAPPA B; PEPTIDE FRAGMENTS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; SEA ANEMONES; SHAW POTASSIUM CHANNELS;

EID: 34548306421     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.039206     Document Type: Short Survey

References (15)

1. Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, and Goldstein SA (2001) MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104:217-231.
2. Abbott GW, Butler MH, and Goldstein SA (2006) Phosphorylation and protonation of neighboring MiRP2 sites: function and pathophysiology of MiRP2-Kv3.4 potassium channels in periodic paralysis. Faseb J 20:293-301.
3. Angulo E, Noe V, Casado V, Mallol J, Gomez-Isla T, Lluis C, Ferrer I, Ciudad CJ, and Franco R (2004) Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. J Neurochem 91:547-557.
4. Antz C, Bauer T, Kalbacher H, Frank R, Covarrubias M, Kalbitzer HR, Ruppersberg JP, Baukrowitz T, and Fakler B (1999) Control of K+ channel gating by protein phosphorylation: structural switches of the inactivation gate. Nat Struct Biol 6:146-150.
5. Baranauskas G, Tkatch T, Nagata K, Yeh JZ, and Surmeier DJ (2003) Kv3.4 subunits enhance the repolarizing efficiency of Kv3.1 channels in fast-spiking neurons. Nat Neurosci 6:258-266.
6. McCrossan ZA, and Abbott GW (2004) The MinK-Related Peptides. Neuropharmacology 47:787-821.
7. McCrossan ZA, Lewis A, Panaghie G, Jordan PN, Christini DJ, Lerner DJ, and Abbott GW (2003) MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain. J Neurosci 23:8077-8091.
8. Pallàs M and Camins A (2006) Molecular and biochemical features in Alzheimer's disease. Curr Pharm Des 12:4389-4408.
9. Pan Y, Xu X, Tong X, and Wang X (2004) Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats. J Neurosci Res 77:94-99.
10. Pannaccione A, Boscia F, Scorziello A, Adornetto A, Castaldo P, Sirabella R, Tagliatatela M, Di Renzo GF, and Annunziato L (2007) Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death. Mol Pharmacol 72:665-673.
11. Plant LD, Webster NJ, Boyle JP, Ramsden M, Freir DB, Peers C, and Pearson HA (2006) Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiol Aging 27:1673-1683.
12. + channel currents in primary cultures of rat cerebellar granule and cortical neurones. J Neurochem 79:699-712.
13. Schröter KH, Ruppersberg JP, Wunder F, Rettig J, Stocker M, and Pongs O (1991) Cloning and functional expression of a TEA-sensitive A-type potassium channel from rat brain. FEBS Lett 278:211-216.
14. + channel. Proc Biol Sci 248:9-18.
15. Yu SP (2003) Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol 70:363-386.